Article Text

Download PDFPDF

Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants
Free
  1. David Bourchier,
  2. Philip J Weston
  1. Newborn Intensive Care, Waikato Hospital, Private Bag 3200, Hamilton, New Zealand
  1. Dr Bourchier.

Abstract

AIM To compare the efficacy of hydrocortisone with dopamine for the treatment of hypotensive, very low birthweight (VLBW) infants.

METHODS Forty infants were randomly allocated to receive either hydrocortisone (n=21) or dopamine (n=19).

RESULTS All 19 infants randomised to dopamine responded; 17 of 21 (81%) did so in the hydrocortisone group. Three of the four non-responders in the hydrocortisone group had clinically significant left to right ductal shunting. The incidence of bronchopulmonary dysplasia, retinopathy of prematurity, intraventricular haemorrhage, necrotising enterocolitis, symptomatic patent ductus arteriosus, hyperglycaemia, sepsis (bacterial or fungal) or survival did not differ between groups. The adrenocorticotrophic hormone (ACTH) stimulated plasma cortisol activity, either before or after treatment, did not differ between the two groups of infants. Although a significant difference in efficacy between dopamine and hydrocortisone was not noted (P = 0.108), there were four treatment failures in the hydrocortisone group, compared with none in the dopamine group.

CONCLUSION Both hydrocortisone and dopamine are effective treatments for hypotension in very low birthweight infants.

  • hydrocortisone
  • dopamine
  • hypotension
  • very low birthweight
  • plasma cortisol

Statistics from Altmetric.com

Footnotes

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.